Cbt Ar Arfid denied due to quantity / dose limits by Humana?

Humana's specific coverage criteria for cbt ar arfid are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Humana Limits the Quantity of CBT-AR Sessions for ARFID — and Why You Can Appeal

CBT-AR (Cognitive Behavioral Therapy for Avoidant/Restrictive Food Intake Disorder) is a structured psychotherapy protocol for ARFID. A quantity-limits denial from Humana typically means the plan has approved a limited number of sessions and is declining to authorize additional sessions. This is one of the most common behavioral health denials, and it is also one of the most consistently overturned when the treating clinician documents ongoing medical necessity and measurable treatment progress that justifies continued care.

## Why This Is Appealable

Humana's quantity limitations for behavioral health services must comply with the Mental Health Parity and Addiction Equity Act (MHPAEA). If Humana imposes session limits on ARFID psychotherapy that it does not impose on comparable physical health rehabilitation (such as physical therapy for a chronic condition), that disparity may constitute a parity violation. Additionally, continued-care denials must be based on the patient's actual clinical status, not on an arbitrary session count. An appeal showing active treatment response, ongoing functional impairment, and a clinically justified remaining treatment plan has a strong record of success.

## Federal Appeal Framework

• Internal appeal: File within the deadline on your denial letter. Under ERISA §503 or applicable state law, Humana must provide a full-and-fair review by a clinician with relevant expertise.
• External review: Under ACA §2719, quantity/session-limit denials for behavioral health are subject to independent external review. The general window is approximately four months from the original denial — use the exact deadline on your denial letter.
• Mental Health Parity: Document the comparable physical health service (e.g., physical therapy for a chronic condition) and whether Humana applies the same session limits to it. This is a powerful secondary argument.
• Expedited review: Request if continued delay in authorization would result in clinical deterioration, particularly relevant for pediatric patients with nutritional compromise.

## Documentation to Gather

1. Progress notes for all completed sessions — documenting measurable progress, treatment goals addressed, and remaining goals not yet achieved. 2. Clinical severity update — current nutritional status, functional impairment, and any safety concerns documented since treatment began. 3. Updated treatment plan — from the treating clinician, specifying the number of additional sessions requested, the clinical rationale, and the measurable goals for the continued phase of treatment. 4. Prescriber/therapist letter — must address Humana's continued-care criteria directly, citing chart evidence of active treatment response and the clinical necessity of additional sessions. 5. Parity comparator data — if available from Humana's own documents, showing how session limits compare to physical health rehabilitation services.

## Criteria-Mapping Structure

Obtain Humana's continued-care or behavioral health coverage criteria for outpatient psychotherapy. Copy each criterion for continued authorization verbatim. In the adjacent column, cite the specific progress note, assessment result, or clinical finding that satisfies it. Unanswered rows are denial risks — ensure the therapist's letter covers every one.

## Next Step

If Humana's denial letter does not identify which continued-care criterion was not met, request that information in writing before or simultaneously with filing the appeal. Knowing the specific gap allows a targeted, efficient response.